Skip to main content
NC Medicaid logo NC Medicaid

Topical Navigation

  • Home
  • Beneficiaries
  • Meetings & Notices
  • Find a Doctor
  • Providers
  • Counties
  • Reports
  • ABOUT US
  • NC.GOV
  • NCDHHS
  • SERVICES
NC Medicaid »   Home »   blog

SPECIAL BULLETIN COVID-19 #217: Third Dose of Pfizer-BioN Tech Vaccine for Children Ages 5-11 Certain immunocompromised children will qualify

January 14, 2022

On Jan. 3, 2022, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for a third dose in the primary series for certain immunocompromised children ages 5 through 11. This includes children who have undergone solid organ transplantation or who have been diagnosed with conditions which are considered to have an equivalent level of immunocompromise. Children ages 5 through 11 who are fully vaccinated and are not immunocompromised do not need a third dose at this time. 

As of Jan. 3, 2022, Medicaid and NC Health Choice will cover a third dose of the Pfizer-BioNTech COVID-19 Vaccine primary series for immunocompromised children ages 5 through 11 for all vaccinating providers.

The new vaccine administration code assigned to the third dose of Pfizer’s pediatric COVID-19 vaccine is:

91307

SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to prevent the patient from contracting COVID–19. 10 mcg/0.2 mL

0073A

Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose

 

All other aspects of claims billing still apply (see COVID-19 Bulletin #196 for details). 

If you have any questions about product-specific information, please contact the Immunization Branch help desk at 877-873-6247 and press option 6. 

CONTACT

NCTracks Contact Center: 800-688-6696

This blog is related to:

  • Bulletins
  • COVID-19
  • Pharmacy Providers
  • Physicians, Physician Assistants and Nurse Practitioners

Related Articles

  • NC Medicaid Electronic Visit Verification Update for Providers Using a Third Party / Alternate EVV Vendor
  • Enhanced Medical Home Payments for Advanced Medical Homes Serving Members Eligible for Tailored Care Management
  • Pharmacy Point of Sale Process at Tailored Plan Launch
  • NC Medicaid Managed Care Provider Update – Aug. 4, 2022
  • SPECIAL BULLETIN COVID-19 #263: New NC Medicaid Webpage to Help Prepare for End of the Federal Public Health Emergency
  • Home Health Electronic Visit Verification Stakeholder Engagement Meeting
  • Vaccine Administration Codes Reimbursement Update
  • Reprocessed Nursing Facility Claims with March 2020 Date of Service Range Requiring Provider Adjustments
  • Provider Reverification Requirements to be Reinstated at End of Federal Health Emergency
  • Independent Lab Reimbursement Changes Effective Aug. 1, 2022
  • Provider Webinar: Monkeypox Update
  • Endoscopy Code Family Updated in NCTracks
  • SPECIAL BULLETIN COVID-19 #262: Extension of Flexibility for Opioid Treatment Program Take-Home Dosing Update
  • FQHC Radiology Services Reimbursement Methodology Revision
  • SPECIAL BULLETIN COVID-19 #261: New Moderna Pediatric Vaccine Codes

Share this page:

  • Facebook
  • Twitter
  • Email
Back to top

Contact Information

NC Medicaid
Division of Health Benefits

2501 Mail Service Center
Raleigh, NC 27699-2501
 
NC Medicaid Contact Center
Phone: 888-245-0179
Monday-Friday 8 a.m. to 5 p.m.
Closed on State holidays. 
 
Visit RelayNC for information about TTY services. 
 
More
 

Recent Tweets

Tweets by @ncdhhs

Follow Us

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • EMPLOYEE DIRECTORY
  • TRANSLATION DISCLAIMER
  • Accessibility
  • Terms of Use
  • Privacy Policy
  • Open Budget
NC Medicaid
https://medicaid.ncdhhs.gov/blog/2022/01/14/special-bulletin-covid-19-217-third-dose-pfizer-bion-tech-vaccine-children-ages-5-11